2Svanes C,Ovrebo K,Soreide O. Ulcer bleeding and perforation: nonsteroidal anti-inflammatory drugs or Helicobacter pylori[J]. Scand J Gastroenterol Suppl,1996,220(11):128-131.
3Hawkey C J. Non-steroidal anti-inflammatory drug gastropathy[J]. Gastroenterology,2000,119(5):521-535.
4Malrertheiner P,Megraud F,O' Morain C,et al. Current concepts in the management of Helicobacter pylori infection the maastricht 22 000 consensus report[J]. Aliment Pharmacol Ther,2002,16(8):167-180.
5Byron C,Mark F. Effects of very low dose daily,long-term aspirin therapy on gastric,duodenal,and rectal prostaglandin levels and on mucosal injury in healthy humans[J].Gastroenterology,1999,117(6):17-25.
6Lanas A,Hirschowitz B I. Toxicity of NSAIDs in the stomach and duodenum[J]. Eur J Gastroenterol Hepatol,1999,11(2):375-381.
7Singh G,Ramey DR,Morfeld D,et al.Gastrointestinal tract complications of nons teroidal anti- inflammatory drug treatment in rheumatoid arthritis:A prospectiv e observational cohort study[].Archives of Internal Medicine.1996
8Hernandez DS,Rodriguez LA.Association between nonsteroidal anti- inflammat ory drugs and upper gastrointestinal tract bleeding/perforation:an overview of epidemiologic studies published in the 1990S[].Archives of Internal Medicine.2000
9Hsu PI,Lai KH,Tseng HH,et al.Risk factors for presentation with bleeding i n patients with Helicobacter pylori- related peptic ulcer diseases[].J Clin Gastr oenterol.2000
10Slattery J,Warlow CP,Shorrock CJ,et al.Risk of gastrointestinal bleedin g during secondary prevention of vascular events with aspirin- analysis of gas trointestinal bleeding during the UK- TLA trial[].Gut.1995